nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—PTGS2—thyroid cancer	0.642	1	CbGaD
Betamethasone—ABCB1—Sorafenib—thyroid cancer	0.00995	0.281	CbGbCtD
Betamethasone—CYP3A4—Vandetanib—thyroid cancer	0.00989	0.279	CbGbCtD
Betamethasone—ABCB1—Doxorubicin—thyroid cancer	0.00603	0.17	CbGbCtD
Betamethasone—CYP3A4—Sorafenib—thyroid cancer	0.00596	0.168	CbGbCtD
Betamethasone—CYP3A4—Doxorubicin—thyroid cancer	0.00362	0.102	CbGbCtD
Betamethasone—PGR—Nuclear signaling by ERBB4—NRG1—thyroid cancer	0.00114	0.0118	CbGpPWpGaD
Betamethasone—NR3C2—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.0011	0.0114	CbGpPWpGaD
Betamethasone—PLA2G1B—head—thyroid cancer	0.00109	0.0993	CbGeAlD
Betamethasone—PGR—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00106	0.011	CbGpPWpGaD
Betamethasone—NR3C2—saliva-secreting gland—thyroid cancer	0.000996	0.0909	CbGeAlD
Betamethasone—NR3C2—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000981	0.0101	CbGpPWpGaD
Betamethasone—CYP19A1—Metapathway biotransformation—CHST14—thyroid cancer	0.000892	0.00923	CbGpPWpGaD
Betamethasone—PGR—Nuclear Receptors—PPARG—thyroid cancer	0.000849	0.00878	CbGpPWpGaD
Betamethasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—thyroid cancer	0.000832	0.00861	CbGpPWpGaD
Betamethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—RXRA—thyroid cancer	0.000794	0.00821	CbGpPWpGaD
Betamethasone—NR3C1—Nuclear Receptors—RXRA—thyroid cancer	0.000777	0.00804	CbGpPWpGaD
Betamethasone—NR3C2—trachea—thyroid cancer	0.000768	0.0701	CbGeAlD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000767	0.00793	CbGpPWpGaD
Betamethasone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—thyroid cancer	0.00076	0.00786	CbGpPWpGaD
Betamethasone—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000748	0.00774	CbGpPWpGaD
Betamethasone—Thrombocytopenia—Vandetanib—thyroid cancer	0.000742	0.00345	CcSEcCtD
Betamethasone—Blister—Epirubicin—thyroid cancer	0.000734	0.00341	CcSEcCtD
Betamethasone—Haemoglobin—Sorafenib—thyroid cancer	0.000723	0.00336	CcSEcCtD
Betamethasone—Haemorrhage—Sorafenib—thyroid cancer	0.000719	0.00334	CcSEcCtD
Betamethasone—NR3C2—Generic Transcription Pathway—THRB—thyroid cancer	0.000709	0.00734	CbGpPWpGaD
Betamethasone—Neuritis—Epirubicin—thyroid cancer	0.000709	0.00329	CcSEcCtD
Betamethasone—Hepatomegaly—Doxorubicin—thyroid cancer	0.000692	0.00321	CcSEcCtD
Betamethasone—Rash erythematous—Epirubicin—thyroid cancer	0.000691	0.00321	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00069	0.00321	CcSEcCtD
Betamethasone—Fungal infection—Epirubicin—thyroid cancer	0.000685	0.00318	CcSEcCtD
Betamethasone—NR3C1—neck—thyroid cancer	0.000685	0.0625	CbGeAlD
Betamethasone—Insomnia—Vandetanib—thyroid cancer	0.000685	0.00318	CcSEcCtD
Betamethasone—Paraesthesia—Vandetanib—thyroid cancer	0.00068	0.00316	CcSEcCtD
Betamethasone—Blister—Doxorubicin—thyroid cancer	0.000679	0.00316	CcSEcCtD
Betamethasone—Necrosis—Epirubicin—thyroid cancer	0.000674	0.00313	CcSEcCtD
Betamethasone—PGR—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000671	0.00694	CbGpPWpGaD
Betamethasone—Abscess—Epirubicin—thyroid cancer	0.000669	0.00311	CcSEcCtD
Betamethasone—Dyspepsia—Vandetanib—thyroid cancer	0.000667	0.0031	CcSEcCtD
Betamethasone—Decreased appetite—Vandetanib—thyroid cancer	0.000658	0.00306	CcSEcCtD
Betamethasone—Neuritis—Doxorubicin—thyroid cancer	0.000656	0.00305	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000654	0.00304	CcSEcCtD
Betamethasone—Stinging—Epirubicin—thyroid cancer	0.000653	0.00304	CcSEcCtD
Betamethasone—Glycosuria—Epirubicin—thyroid cancer	0.000653	0.00304	CcSEcCtD
Betamethasone—Fatigue—Vandetanib—thyroid cancer	0.000653	0.00303	CcSEcCtD
Betamethasone—Angiopathy—Sorafenib—thyroid cancer	0.000652	0.00303	CcSEcCtD
Betamethasone—Pain—Vandetanib—thyroid cancer	0.000648	0.00301	CcSEcCtD
Betamethasone—Petechiae—Epirubicin—thyroid cancer	0.000643	0.00299	CcSEcCtD
Betamethasone—Arrhythmia—Sorafenib—thyroid cancer	0.000642	0.00298	CcSEcCtD
Betamethasone—Rash erythematous—Doxorubicin—thyroid cancer	0.000639	0.00297	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—RET—thyroid cancer	0.000636	0.00658	CbGpPWpGaD
Betamethasone—Alopecia—Sorafenib—thyroid cancer	0.000635	0.00295	CcSEcCtD
Betamethasone—Fungal infection—Doxorubicin—thyroid cancer	0.000634	0.00295	CcSEcCtD
Betamethasone—Erythema—Sorafenib—thyroid cancer	0.000626	0.00291	CcSEcCtD
Betamethasone—Necrosis—Doxorubicin—thyroid cancer	0.000624	0.0029	CcSEcCtD
Betamethasone—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000619	0.00288	CcSEcCtD
Betamethasone—Abscess—Doxorubicin—thyroid cancer	0.000619	0.00288	CcSEcCtD
Betamethasone—NR3C1—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.000614	0.00635	CbGpPWpGaD
Betamethasone—CYP19A1—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000612	0.00633	CbGpPWpGaD
Betamethasone—NR3C2—thyroid gland—thyroid cancer	0.000608	0.0554	CbGeAlD
Betamethasone—Extravasation—Epirubicin—thyroid cancer	0.000607	0.00282	CcSEcCtD
Betamethasone—Glycosuria—Doxorubicin—thyroid cancer	0.000604	0.00281	CcSEcCtD
Betamethasone—Stinging—Doxorubicin—thyroid cancer	0.000604	0.00281	CcSEcCtD
Betamethasone—Amenorrhoea—Epirubicin—thyroid cancer	0.000602	0.0028	CcSEcCtD
Betamethasone—Body temperature increased—Vandetanib—thyroid cancer	0.000599	0.00278	CcSEcCtD
Betamethasone—Abdominal pain—Vandetanib—thyroid cancer	0.000599	0.00278	CcSEcCtD
Betamethasone—PGR—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000598	0.00618	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of Androgen receptor activity—RXRA—thyroid cancer	0.000596	0.00616	CbGpPWpGaD
Betamethasone—Petechiae—Doxorubicin—thyroid cancer	0.000595	0.00277	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.000591	0.00611	CbGpPWpGaD
Betamethasone—Arthropathy—Epirubicin—thyroid cancer	0.000582	0.0027	CcSEcCtD
Betamethasone—NR3C1—Circadian Clock—RXRA—thyroid cancer	0.000578	0.00598	CbGpPWpGaD
Betamethasone—Herpes simplex—Epirubicin—thyroid cancer	0.000574	0.00267	CcSEcCtD
Betamethasone—Angioedema—Sorafenib—thyroid cancer	0.000572	0.00266	CcSEcCtD
Betamethasone—PGR—thyroid gland—thyroid cancer	0.000565	0.0515	CbGeAlD
Betamethasone—Syncope—Sorafenib—thyroid cancer	0.000561	0.00261	CcSEcCtD
Betamethasone—Extravasation—Doxorubicin—thyroid cancer	0.000561	0.00261	CcSEcCtD
Betamethasone—Ulcer—Epirubicin—thyroid cancer	0.00056	0.0026	CcSEcCtD
Betamethasone—Amenorrhoea—Doxorubicin—thyroid cancer	0.000557	0.00259	CcSEcCtD
Betamethasone—Loss of consciousness—Sorafenib—thyroid cancer	0.00055	0.00256	CcSEcCtD
Betamethasone—Asthenia—Vandetanib—thyroid cancer	0.000543	0.00252	CcSEcCtD
Betamethasone—Hypertension—Sorafenib—thyroid cancer	0.00054	0.00251	CcSEcCtD
Betamethasone—NR3C2—head—thyroid cancer	0.000539	0.0492	CbGeAlD
Betamethasone—Arthropathy—Doxorubicin—thyroid cancer	0.000539	0.0025	CcSEcCtD
Betamethasone—Pruritus—Vandetanib—thyroid cancer	0.000536	0.00249	CcSEcCtD
Betamethasone—NR3C1—saliva-secreting gland—thyroid cancer	0.000534	0.0487	CbGeAlD
Betamethasone—Myalgia—Sorafenib—thyroid cancer	0.000533	0.00248	CcSEcCtD
Betamethasone—Herpes simplex—Doxorubicin—thyroid cancer	0.000531	0.00247	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—MINPP1—thyroid cancer	0.00053	0.00548	CbGpPWpGaD
Betamethasone—Hiccups—Epirubicin—thyroid cancer	0.000529	0.00246	CcSEcCtD
Betamethasone—Dermatitis contact—Epirubicin—thyroid cancer	0.000523	0.00243	CcSEcCtD
Betamethasone—Diarrhoea—Vandetanib—thyroid cancer	0.000518	0.00241	CcSEcCtD
Betamethasone—Ulcer—Doxorubicin—thyroid cancer	0.000518	0.00241	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—CDK1—thyroid cancer	0.000514	0.00531	CbGpPWpGaD
Betamethasone—Anaphylactic shock—Sorafenib—thyroid cancer	0.000511	0.00237	CcSEcCtD
Betamethasone—CYP19A1—thyroid gland—thyroid cancer	0.000509	0.0464	CbGeAlD
Betamethasone—Infection—Sorafenib—thyroid cancer	0.000508	0.00236	CcSEcCtD
Betamethasone—Skin exfoliation—Epirubicin—thyroid cancer	0.000505	0.00235	CcSEcCtD
Betamethasone—Shock—Sorafenib—thyroid cancer	0.000503	0.00234	CcSEcCtD
Betamethasone—Fluid retention—Epirubicin—thyroid cancer	0.000502	0.00233	CcSEcCtD
Betamethasone—PGR—head—thyroid cancer	0.000501	0.0457	CbGeAlD
Betamethasone—Nervous system disorder—Sorafenib—thyroid cancer	0.000501	0.00233	CcSEcCtD
Betamethasone—Dizziness—Vandetanib—thyroid cancer	0.000501	0.00233	CcSEcCtD
Betamethasone—Thrombocytopenia—Sorafenib—thyroid cancer	0.0005	0.00232	CcSEcCtD
Betamethasone—Neuropathy—Epirubicin—thyroid cancer	0.000497	0.00231	CcSEcCtD
Betamethasone—CYP19A1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000496	0.00513	CbGpPWpGaD
Betamethasone—NR3C1—Nuclear Receptors—PPARG—thyroid cancer	0.000491	0.00508	CbGpPWpGaD
Betamethasone—Hiccups—Doxorubicin—thyroid cancer	0.00049	0.00228	CcSEcCtD
Betamethasone—Dry eye—Epirubicin—thyroid cancer	0.000489	0.00227	CcSEcCtD
Betamethasone—Anorexia—Sorafenib—thyroid cancer	0.000487	0.00226	CcSEcCtD
Betamethasone—Dermatitis contact—Doxorubicin—thyroid cancer	0.000484	0.00225	CcSEcCtD
Betamethasone—Oesophagitis—Epirubicin—thyroid cancer	0.000484	0.00225	CcSEcCtD
Betamethasone—Vomiting—Vandetanib—thyroid cancer	0.000482	0.00224	CcSEcCtD
Betamethasone—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000479	0.00496	CbGpPWpGaD
Betamethasone—Ecchymosis—Epirubicin—thyroid cancer	0.000479	0.00222	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—CDK1—thyroid cancer	0.000478	0.00494	CbGpPWpGaD
Betamethasone—Rash—Vandetanib—thyroid cancer	0.000478	0.00222	CcSEcCtD
Betamethasone—Dermatitis—Vandetanib—thyroid cancer	0.000477	0.00222	CcSEcCtD
Betamethasone—Headache—Vandetanib—thyroid cancer	0.000474	0.0022	CcSEcCtD
Betamethasone—NR3C2—Gene Expression—TRIM33—thyroid cancer	0.000472	0.00489	CbGpPWpGaD
Betamethasone—Pulmonary oedema—Epirubicin—thyroid cancer	0.000471	0.00219	CcSEcCtD
Betamethasone—Skin exfoliation—Doxorubicin—thyroid cancer	0.000468	0.00217	CcSEcCtD
Betamethasone—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—HRAS—thyroid cancer	0.000467	0.00483	CbGpPWpGaD
Betamethasone—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000465	0.00216	CcSEcCtD
Betamethasone—Fluid retention—Doxorubicin—thyroid cancer	0.000465	0.00216	CcSEcCtD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—TPR—thyroid cancer	0.000465	0.00481	CbGpPWpGaD
Betamethasone—Neuropathy—Doxorubicin—thyroid cancer	0.00046	0.00214	CcSEcCtD
Betamethasone—Dry eye—Doxorubicin—thyroid cancer	0.000452	0.0021	CcSEcCtD
Betamethasone—CYP19A1—head—thyroid cancer	0.000451	0.0411	CbGeAlD
Betamethasone—PLA2G1B—Metabolism—NDUFA13—thyroid cancer	0.000451	0.00466	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—MEN1—thyroid cancer	0.00045	0.00466	CbGpPWpGaD
Betamethasone—Nausea—Vandetanib—thyroid cancer	0.00045	0.00209	CcSEcCtD
Betamethasone—Dyspepsia—Sorafenib—thyroid cancer	0.00045	0.00209	CcSEcCtD
Betamethasone—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000448	0.00463	CbGpPWpGaD
Betamethasone—Oesophagitis—Doxorubicin—thyroid cancer	0.000447	0.00208	CcSEcCtD
Betamethasone—Decreased appetite—Sorafenib—thyroid cancer	0.000444	0.00206	CcSEcCtD
Betamethasone—Thrombophlebitis—Epirubicin—thyroid cancer	0.000444	0.00206	CcSEcCtD
Betamethasone—Ecchymosis—Doxorubicin—thyroid cancer	0.000443	0.00206	CcSEcCtD
Betamethasone—Diabetes mellitus—Epirubicin—thyroid cancer	0.000442	0.00205	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000441	0.00205	CcSEcCtD
Betamethasone—Fatigue—Sorafenib—thyroid cancer	0.00044	0.00205	CcSEcCtD
Betamethasone—Pain—Sorafenib—thyroid cancer	0.000437	0.00203	CcSEcCtD
Betamethasone—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000436	0.00203	CcSEcCtD
Betamethasone—PGR—Generic Transcription Pathway—THRB—thyroid cancer	0.000432	0.00447	CbGpPWpGaD
Betamethasone—NR3C1—Circadian Clock—HIF1A—thyroid cancer	0.000429	0.00444	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000427	0.00442	CbGpPWpGaD
Betamethasone—Eye pain—Epirubicin—thyroid cancer	0.000426	0.00198	CcSEcCtD
Betamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000425	0.0044	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CHST14—thyroid cancer	0.000424	0.00438	CbGpPWpGaD
Betamethasone—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000424	0.00197	CcSEcCtD
Betamethasone—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000418	0.00194	CcSEcCtD
Betamethasone—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—AKT1—thyroid cancer	0.000413	0.00427	CbGpPWpGaD
Betamethasone—NR3C1—trachea—thyroid cancer	0.000412	0.0376	CbGeAlD
Betamethasone—Thrombophlebitis—Doxorubicin—thyroid cancer	0.000411	0.00191	CcSEcCtD
Betamethasone—Increased appetite—Epirubicin—thyroid cancer	0.000409	0.0019	CcSEcCtD
Betamethasone—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000409	0.0019	CcSEcCtD
Betamethasone—Urticaria—Sorafenib—thyroid cancer	0.000406	0.00189	CcSEcCtD
Betamethasone—Body temperature increased—Sorafenib—thyroid cancer	0.000404	0.00188	CcSEcCtD
Betamethasone—Abdominal pain—Sorafenib—thyroid cancer	0.000404	0.00188	CcSEcCtD
Betamethasone—Dermatitis bullous—Epirubicin—thyroid cancer	0.000402	0.00187	CcSEcCtD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—CCND1—thyroid cancer	0.000398	0.00411	CbGpPWpGaD
Betamethasone—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000397	0.00184	CcSEcCtD
Betamethasone—Eye pain—Doxorubicin—thyroid cancer	0.000394	0.00183	CcSEcCtD
Betamethasone—Cardiac failure—Epirubicin—thyroid cancer	0.000394	0.00183	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.000393	0.00406	CbGpPWpGaD
Betamethasone—Lethargy—Epirubicin—thyroid cancer	0.000392	0.00182	CcSEcCtD
Betamethasone—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000392	0.00182	CcSEcCtD
Betamethasone—NR3C1—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000388	0.00401	CbGpPWpGaD
Betamethasone—Osteoarthritis—Epirubicin—thyroid cancer	0.000384	0.00178	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—NRG1—thyroid cancer	0.000384	0.00397	CbGpPWpGaD
Betamethasone—Increased appetite—Doxorubicin—thyroid cancer	0.000378	0.00176	CcSEcCtD
Betamethasone—Migraine—Epirubicin—thyroid cancer	0.000378	0.00176	CcSEcCtD
Betamethasone—Affect lability—Epirubicin—thyroid cancer	0.000378	0.00176	CcSEcCtD
Betamethasone—NR3C2—lymph node—thyroid cancer	0.000378	0.0344	CbGeAlD
Betamethasone—PTGS2—Spinal Cord Injury—LGALS3—thyroid cancer	0.000375	0.00388	CbGpPWpGaD
Betamethasone—PLA2G1B—Phospholipid metabolism—PTEN—thyroid cancer	0.000373	0.00385	CbGpPWpGaD
Betamethasone—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000372	0.00173	CcSEcCtD
Betamethasone—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000367	0.00171	CcSEcCtD
Betamethasone—Asthenia—Sorafenib—thyroid cancer	0.000367	0.0017	CcSEcCtD
Betamethasone—Cardiac arrest—Epirubicin—thyroid cancer	0.000365	0.0017	CcSEcCtD
Betamethasone—Cardiac failure—Doxorubicin—thyroid cancer	0.000364	0.00169	CcSEcCtD
Betamethasone—Mood swings—Epirubicin—thyroid cancer	0.000364	0.00169	CcSEcCtD
Betamethasone—Lethargy—Doxorubicin—thyroid cancer	0.000363	0.00169	CcSEcCtD
Betamethasone—Pruritus—Sorafenib—thyroid cancer	0.000361	0.00168	CcSEcCtD
Betamethasone—PTGS2—trachea—thyroid cancer	0.000357	0.0325	CbGeAlD
Betamethasone—Osteoarthritis—Doxorubicin—thyroid cancer	0.000355	0.00165	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—HIF1A—thyroid cancer	0.000354	0.00366	CbGpPWpGaD
Betamethasone—Dry skin—Epirubicin—thyroid cancer	0.000352	0.00164	CcSEcCtD
Betamethasone—PGR—lymph node—thyroid cancer	0.000351	0.032	CbGeAlD
Betamethasone—Migraine—Doxorubicin—thyroid cancer	0.00035	0.00163	CcSEcCtD
Betamethasone—Affect lability—Doxorubicin—thyroid cancer	0.00035	0.00163	CcSEcCtD
Betamethasone—Hypokalaemia—Epirubicin—thyroid cancer	0.00035	0.00162	CcSEcCtD
Betamethasone—Diarrhoea—Sorafenib—thyroid cancer	0.00035	0.00162	CcSEcCtD
Betamethasone—NR3C1—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000345	0.00357	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—THRB—thyroid cancer	0.000342	0.00353	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—HPGD—thyroid cancer	0.000341	0.00353	CbGpPWpGaD
Betamethasone—Muscular weakness—Epirubicin—thyroid cancer	0.000339	0.00157	CcSEcCtD
Betamethasone—Cardiac arrest—Doxorubicin—thyroid cancer	0.000338	0.00157	CcSEcCtD
Betamethasone—Dizziness—Sorafenib—thyroid cancer	0.000338	0.00157	CcSEcCtD
Betamethasone—Mood swings—Doxorubicin—thyroid cancer	0.000337	0.00156	CcSEcCtD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000335	0.00346	CbGpPWpGaD
Betamethasone—NR3C1—thyroid gland—thyroid cancer	0.000326	0.0297	CbGeAlD
Betamethasone—Dry skin—Doxorubicin—thyroid cancer	0.000326	0.00151	CcSEcCtD
Betamethasone—Vomiting—Sorafenib—thyroid cancer	0.000325	0.00151	CcSEcCtD
Betamethasone—Hypokalaemia—Doxorubicin—thyroid cancer	0.000324	0.0015	CcSEcCtD
Betamethasone—Rash—Sorafenib—thyroid cancer	0.000322	0.0015	CcSEcCtD
Betamethasone—Dermatitis—Sorafenib—thyroid cancer	0.000322	0.0015	CcSEcCtD
Betamethasone—Headache—Sorafenib—thyroid cancer	0.00032	0.00149	CcSEcCtD
Betamethasone—CYP19A1—lymph node—thyroid cancer	0.000316	0.0288	CbGeAlD
Betamethasone—Muscular weakness—Doxorubicin—thyroid cancer	0.000314	0.00146	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—SST—thyroid cancer	0.00031	0.00321	CbGpPWpGaD
Betamethasone—Nausea—Sorafenib—thyroid cancer	0.000303	0.00141	CcSEcCtD
Betamethasone—Weight increased—Epirubicin—thyroid cancer	0.000302	0.0014	CcSEcCtD
Betamethasone—NR3C2—Generic Transcription Pathway—RXRA—thyroid cancer	0.000301	0.00312	CbGpPWpGaD
Betamethasone—Weight decreased—Epirubicin—thyroid cancer	0.0003	0.0014	CcSEcCtD
Betamethasone—Hyperglycaemia—Epirubicin—thyroid cancer	0.0003	0.00139	CcSEcCtD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—thyroid cancer	0.000299	0.00309	CbGpPWpGaD
Betamethasone—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000295	0.00305	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—RXRA—thyroid cancer	0.000291	0.00301	CbGpPWpGaD
Betamethasone—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00029	0.00135	CcSEcCtD
Betamethasone—NR3C1—head—thyroid cancer	0.000289	0.0264	CbGeAlD
Betamethasone—CYP19A1—FSH signaling pathway—AKT1—thyroid cancer	0.000289	0.00299	CbGpPWpGaD
Betamethasone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000288	0.00298	CbGpPWpGaD
Betamethasone—Conjunctivitis—Epirubicin—thyroid cancer	0.000288	0.00134	CcSEcCtD
Betamethasone—PGR—Gene Expression—TRIM33—thyroid cancer	0.000288	0.00298	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00028	0.0029	CbGpPWpGaD
Betamethasone—Weight increased—Doxorubicin—thyroid cancer	0.00028	0.0013	CcSEcCtD
Betamethasone—Weight decreased—Doxorubicin—thyroid cancer	0.000278	0.00129	CcSEcCtD
Betamethasone—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000277	0.00129	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000277	0.00287	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—MEN1—thyroid cancer	0.000274	0.00284	CbGpPWpGaD
Betamethasone—Bradycardia—Epirubicin—thyroid cancer	0.000271	0.00126	CcSEcCtD
Betamethasone—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000269	0.00125	CcSEcCtD
Betamethasone—Haemoglobin—Epirubicin—thyroid cancer	0.000267	0.00124	CcSEcCtD
Betamethasone—Conjunctivitis—Doxorubicin—thyroid cancer	0.000266	0.00124	CcSEcCtD
Betamethasone—Haemorrhage—Epirubicin—thyroid cancer	0.000266	0.00123	CcSEcCtD
Betamethasone—CYP19A1—Biological oxidations—RXRA—thyroid cancer	0.000263	0.00272	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.00026	0.00269	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CDK1—thyroid cancer	0.000256	0.00265	CbGpPWpGaD
Betamethasone—Visual impairment—Epirubicin—thyroid cancer	0.000256	0.00119	CcSEcCtD
Betamethasone—PTGS2—head—thyroid cancer	0.00025	0.0228	CbGeAlD
Betamethasone—Bradycardia—Doxorubicin—thyroid cancer	0.00025	0.00116	CcSEcCtD
Betamethasone—NR3C1—Generic Transcription Pathway—THRB—thyroid cancer	0.00025	0.00258	CbGpPWpGaD
Betamethasone—Eye disorder—Epirubicin—thyroid cancer	0.000248	0.00115	CcSEcCtD
Betamethasone—Haemoglobin—Doxorubicin—thyroid cancer	0.000247	0.00115	CcSEcCtD
Betamethasone—Haemorrhage—Doxorubicin—thyroid cancer	0.000246	0.00114	CcSEcCtD
Betamethasone—Angiopathy—Epirubicin—thyroid cancer	0.000241	0.00112	CcSEcCtD
Betamethasone—Arrhythmia—Epirubicin—thyroid cancer	0.000237	0.0011	CcSEcCtD
Betamethasone—Visual impairment—Doxorubicin—thyroid cancer	0.000237	0.0011	CcSEcCtD
Betamethasone—Alopecia—Epirubicin—thyroid cancer	0.000235	0.00109	CcSEcCtD
Betamethasone—Erythema—Epirubicin—thyroid cancer	0.000231	0.00107	CcSEcCtD
Betamethasone—NR3C2—Gene Expression—TPR—thyroid cancer	0.000231	0.00239	CbGpPWpGaD
Betamethasone—Eye disorder—Doxorubicin—thyroid cancer	0.00023	0.00107	CcSEcCtD
Betamethasone—Angiopathy—Doxorubicin—thyroid cancer	0.000223	0.00104	CcSEcCtD
Betamethasone—ABCB1—trachea—thyroid cancer	0.000221	0.0201	CbGeAlD
Betamethasone—Arrhythmia—Doxorubicin—thyroid cancer	0.00022	0.00102	CcSEcCtD
Betamethasone—Alopecia—Doxorubicin—thyroid cancer	0.000217	0.00101	CcSEcCtD
Betamethasone—NR3C2—Gene Expression—MEN1—thyroid cancer	0.000217	0.00224	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—HIF1A—thyroid cancer	0.000216	0.00223	CbGpPWpGaD
Betamethasone—Ill-defined disorder—Epirubicin—thyroid cancer	0.000215	0.000997	CcSEcCtD
Betamethasone—Erythema—Doxorubicin—thyroid cancer	0.000214	0.000995	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—CCND1—thyroid cancer	0.000214	0.00221	CbGpPWpGaD
Betamethasone—Malaise—Epirubicin—thyroid cancer	0.000209	0.000969	CcSEcCtD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000208	0.00216	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—THRB—thyroid cancer	0.000208	0.00215	CbGpPWpGaD
Betamethasone—Vertigo—Epirubicin—thyroid cancer	0.000208	0.000966	CcSEcCtD
Betamethasone—Syncope—Epirubicin—thyroid cancer	0.000207	0.000964	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—PTEN—thyroid cancer	0.000207	0.00214	CbGpPWpGaD
Betamethasone—Loss of consciousness—Epirubicin—thyroid cancer	0.000203	0.000945	CcSEcCtD
Betamethasone—NR3C1—lymph node—thyroid cancer	0.000203	0.0185	CbGeAlD
Betamethasone—Convulsion—Epirubicin—thyroid cancer	0.0002	0.000931	CcSEcCtD
Betamethasone—Hypertension—Epirubicin—thyroid cancer	0.0002	0.000928	CcSEcCtD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000199	0.00206	CbGpPWpGaD
Betamethasone—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000199	0.000923	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—CALCB—thyroid cancer	0.000197	0.00204	CbGpPWpGaD
Betamethasone—Myalgia—Epirubicin—thyroid cancer	0.000197	0.000915	CcSEcCtD
Betamethasone—Anxiety—Epirubicin—thyroid cancer	0.000196	0.000912	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—TPR—thyroid cancer	0.000196	0.00203	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000195	0.00202	CbGpPWpGaD
Betamethasone—Discomfort—Epirubicin—thyroid cancer	0.000195	0.000904	CcSEcCtD
Betamethasone—CYP19A1—Metabolism—MINPP1—thyroid cancer	0.000194	0.002	CbGpPWpGaD
Betamethasone—Malaise—Doxorubicin—thyroid cancer	0.000193	0.000897	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—PRKAR1A—thyroid cancer	0.000193	0.002	CbGpPWpGaD
Betamethasone—Vertigo—Doxorubicin—thyroid cancer	0.000192	0.000894	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—PTEN—thyroid cancer	0.000192	0.00199	CbGpPWpGaD
Betamethasone—Syncope—Doxorubicin—thyroid cancer	0.000192	0.000892	CcSEcCtD
Betamethasone—NR3C2—Generic Transcription Pathway—PPARG—thyroid cancer	0.00019	0.00197	CbGpPWpGaD
Betamethasone—Anaphylactic shock—Epirubicin—thyroid cancer	0.000189	0.000877	CcSEcCtD
Betamethasone—Oedema—Epirubicin—thyroid cancer	0.000189	0.000877	CcSEcCtD
Betamethasone—Loss of consciousness—Doxorubicin—thyroid cancer	0.000188	0.000874	CcSEcCtD
Betamethasone—Infection—Epirubicin—thyroid cancer	0.000188	0.000872	CcSEcCtD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000187	0.00194	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TRIM33—thyroid cancer	0.000187	0.00193	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000186	0.00193	CbGpPWpGaD
Betamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	0.000186	0.00192	CbGpPWpGaD
Betamethasone—Shock—Epirubicin—thyroid cancer	0.000186	0.000863	CcSEcCtD
Betamethasone—Convulsion—Doxorubicin—thyroid cancer	0.000185	0.000862	CcSEcCtD
Betamethasone—Nervous system disorder—Epirubicin—thyroid cancer	0.000185	0.00086	CcSEcCtD
Betamethasone—Thrombocytopenia—Epirubicin—thyroid cancer	0.000185	0.000859	CcSEcCtD
Betamethasone—Hypertension—Doxorubicin—thyroid cancer	0.000185	0.000859	CcSEcCtD
Betamethasone—Tachycardia—Epirubicin—thyroid cancer	0.000184	0.000856	CcSEcCtD
Betamethasone—PGR—Generic Transcription Pathway—RXRA—thyroid cancer	0.000184	0.0019	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—PPARG—thyroid cancer	0.000183	0.0019	CbGpPWpGaD
Betamethasone—Hyperhidrosis—Epirubicin—thyroid cancer	0.000183	0.000848	CcSEcCtD
Betamethasone—Myalgia—Doxorubicin—thyroid cancer	0.000182	0.000847	CcSEcCtD
Betamethasone—Anxiety—Doxorubicin—thyroid cancer	0.000182	0.000844	CcSEcCtD
Betamethasone—Discomfort—Doxorubicin—thyroid cancer	0.00018	0.000837	CcSEcCtD
Betamethasone—Anorexia—Epirubicin—thyroid cancer	0.00018	0.000836	CcSEcCtD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.00018	0.00186	CbGpPWpGaD
Betamethasone—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000179	0.00185	CbGpPWpGaD
Betamethasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000178	0.00184	CbGpPWpGaD
Betamethasone—Hypotension—Epirubicin—thyroid cancer	0.000176	0.00082	CcSEcCtD
Betamethasone—PTGS2—lymph node—thyroid cancer	0.000175	0.016	CbGeAlD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000175	0.00181	CbGpPWpGaD
Betamethasone—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000175	0.000812	CcSEcCtD
Betamethasone—Oedema—Doxorubicin—thyroid cancer	0.000175	0.000812	CcSEcCtD
Betamethasone—ABCB1—thyroid gland—thyroid cancer	0.000175	0.0159	CbGeAlD
Betamethasone—Infection—Doxorubicin—thyroid cancer	0.000174	0.000806	CcSEcCtD
Betamethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.000173	0.00178	CbGpPWpGaD
Betamethasone—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000172	0.000799	CcSEcCtD
Betamethasone—Shock—Doxorubicin—thyroid cancer	0.000172	0.000799	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—NRAS—thyroid cancer	0.000171	0.00177	CbGpPWpGaD
Betamethasone—Nervous system disorder—Doxorubicin—thyroid cancer	0.000171	0.000796	CcSEcCtD
Betamethasone—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000171	0.000795	CcSEcCtD
Betamethasone—Insomnia—Epirubicin—thyroid cancer	0.000171	0.000793	CcSEcCtD
Betamethasone—Tachycardia—Doxorubicin—thyroid cancer	0.000171	0.000792	CcSEcCtD
Betamethasone—Paraesthesia—Epirubicin—thyroid cancer	0.00017	0.000788	CcSEcCtD
Betamethasone—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000169	0.000785	CcSEcCtD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000168	0.00174	CbGpPWpGaD
Betamethasone—Anorexia—Doxorubicin—thyroid cancer	0.000167	0.000774	CcSEcCtD
Betamethasone—NR3C1—Gene Expression—TRIM33—thyroid cancer	0.000166	0.00172	CbGpPWpGaD
Betamethasone—Dyspepsia—Epirubicin—thyroid cancer	0.000166	0.000772	CcSEcCtD
Betamethasone—CYP19A1—Metabolism—NDUFA13—thyroid cancer	0.000165	0.0017	CbGpPWpGaD
Betamethasone—Decreased appetite—Epirubicin—thyroid cancer	0.000164	0.000763	CcSEcCtD
Betamethasone—Hypotension—Doxorubicin—thyroid cancer	0.000163	0.000758	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000163	0.000757	CcSEcCtD
Betamethasone—Fatigue—Epirubicin—thyroid cancer	0.000163	0.000756	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000162	0.00167	CbGpPWpGaD
Betamethasone—Pain—Epirubicin—thyroid cancer	0.000161	0.00075	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000159	0.00074	CcSEcCtD
Betamethasone—NR3C1—Generic Transcription Pathway—MEN1—thyroid cancer	0.000159	0.00164	CbGpPWpGaD
Betamethasone—Insomnia—Doxorubicin—thyroid cancer	0.000158	0.000734	CcSEcCtD
Betamethasone—Paraesthesia—Doxorubicin—thyroid cancer	0.000157	0.000729	CcSEcCtD
Betamethasone—Feeling abnormal—Epirubicin—thyroid cancer	0.000156	0.000723	CcSEcCtD
Betamethasone—ABCB1—head—thyroid cancer	0.000155	0.0141	CbGeAlD
Betamethasone—CYP19A1—Metabolism—CHST14—thyroid cancer	0.000155	0.0016	CbGpPWpGaD
Betamethasone—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000154	0.000717	CcSEcCtD
Betamethasone—Dyspepsia—Doxorubicin—thyroid cancer	0.000154	0.000715	CcSEcCtD
Betamethasone—Decreased appetite—Doxorubicin—thyroid cancer	0.000152	0.000706	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000151	0.000701	CcSEcCtD
Betamethasone—Fatigue—Doxorubicin—thyroid cancer	0.000151	0.0007	CcSEcCtD
Betamethasone—Urticaria—Epirubicin—thyroid cancer	0.00015	0.000697	CcSEcCtD
Betamethasone—Pain—Doxorubicin—thyroid cancer	0.000149	0.000694	CcSEcCtD
Betamethasone—Body temperature increased—Epirubicin—thyroid cancer	0.000149	0.000694	CcSEcCtD
Betamethasone—Abdominal pain—Epirubicin—thyroid cancer	0.000149	0.000694	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—KRAS—thyroid cancer	0.000148	0.00153	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—SLC5A5—thyroid cancer	0.000147	0.00152	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—RXRA—thyroid cancer	0.000145	0.0015	CbGpPWpGaD
Betamethasone—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000145	0.0015	CbGpPWpGaD
Betamethasone—Feeling abnormal—Doxorubicin—thyroid cancer	0.000144	0.000669	CcSEcCtD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000143	0.00148	CbGpPWpGaD
Betamethasone—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000143	0.000664	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—TP53—thyroid cancer	0.000141	0.00146	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—TPR—thyroid cancer	0.00014	0.00145	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—CCND1—thyroid cancer	0.00014	0.00145	CbGpPWpGaD
Betamethasone—Urticaria—Doxorubicin—thyroid cancer	0.000139	0.000645	CcSEcCtD
Betamethasone—Abdominal pain—Doxorubicin—thyroid cancer	0.000138	0.000642	CcSEcCtD
Betamethasone—Body temperature increased—Doxorubicin—thyroid cancer	0.000138	0.000642	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000138	0.00142	CbGpPWpGaD
Betamethasone—Asthenia—Epirubicin—thyroid cancer	0.000135	0.000629	CcSEcCtD
Betamethasone—Pruritus—Epirubicin—thyroid cancer	0.000134	0.000621	CcSEcCtD
Betamethasone—PGR—Gene Expression—MEN1—thyroid cancer	0.000132	0.00137	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TRIM24—thyroid cancer	0.000131	0.00136	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.000131	0.00136	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—MINPP1—thyroid cancer	0.000129	0.00134	CbGpPWpGaD
Betamethasone—Diarrhoea—Epirubicin—thyroid cancer	0.000129	0.0006	CcSEcCtD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000127	0.00131	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—HRAS—thyroid cancer	0.000125	0.0013	CbGpPWpGaD
Betamethasone—Asthenia—Doxorubicin—thyroid cancer	0.000125	0.000582	CcSEcCtD
Betamethasone—Dizziness—Epirubicin—thyroid cancer	0.000125	0.00058	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—TCF7L1—thyroid cancer	0.000125	0.00129	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—HPGD—thyroid cancer	0.000125	0.00129	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—thyroid cancer	0.000124	0.00128	CbGpPWpGaD
Betamethasone—Pruritus—Doxorubicin—thyroid cancer	0.000124	0.000574	CcSEcCtD
Betamethasone—PTGS2—Disease—CHST14—thyroid cancer	0.000123	0.00128	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—RXRA—thyroid cancer	0.000123	0.00128	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—NRAS—thyroid cancer	0.000121	0.00125	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—THRB—thyroid cancer	0.00012	0.00124	CbGpPWpGaD
Betamethasone—Vomiting—Epirubicin—thyroid cancer	0.00012	0.000558	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.00012	0.00124	CbGpPWpGaD
Betamethasone—Diarrhoea—Doxorubicin—thyroid cancer	0.00012	0.000555	CcSEcCtD
Betamethasone—Rash—Epirubicin—thyroid cancer	0.000119	0.000553	CcSEcCtD
Betamethasone—Dermatitis—Epirubicin—thyroid cancer	0.000119	0.000553	CcSEcCtD
Betamethasone—Headache—Epirubicin—thyroid cancer	0.000118	0.00055	CcSEcCtD
Betamethasone—PTGS2—Disease—TRIM33—thyroid cancer	0.000117	0.00121	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—PPARG—thyroid cancer	0.000116	0.0012	CbGpPWpGaD
Betamethasone—Dizziness—Doxorubicin—thyroid cancer	0.000116	0.000537	CcSEcCtD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000115	0.00119	CbGpPWpGaD
Betamethasone—Nausea—Epirubicin—thyroid cancer	0.000112	0.000521	CcSEcCtD
Betamethasone—Vomiting—Doxorubicin—thyroid cancer	0.000111	0.000516	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—AKT1—thyroid cancer	0.000111	0.00115	CbGpPWpGaD
Betamethasone—Rash—Doxorubicin—thyroid cancer	0.00011	0.000512	CcSEcCtD
Betamethasone—Dermatitis—Doxorubicin—thyroid cancer	0.00011	0.000511	CcSEcCtD
Betamethasone—PTGS2—Metabolism—NDUFA13—thyroid cancer	0.00011	0.00114	CbGpPWpGaD
Betamethasone—Headache—Doxorubicin—thyroid cancer	0.000109	0.000509	CcSEcCtD
Betamethasone—ABCB1—lymph node—thyroid cancer	0.000108	0.00989	CbGeAlD
Betamethasone—PTGS2—Spinal Cord Injury—CCND1—thyroid cancer	0.000107	0.0011	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—RXRA—thyroid cancer	0.000106	0.0011	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.000106	0.0011	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—thyroid cancer	0.000105	0.00108	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—KRAS—thyroid cancer	0.000104	0.00107	CbGpPWpGaD
Betamethasone—Nausea—Doxorubicin—thyroid cancer	0.000104	0.000482	CcSEcCtD
Betamethasone—PTGS2—Metabolism—CHST14—thyroid cancer	0.000103	0.00107	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000101	0.00105	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	9.72e-05	0.00101	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—MINPP1—thyroid cancer	9.17e-05	0.000948	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—PPARG—thyroid cancer	9.16e-05	0.000948	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TSHR—thyroid cancer	9.13e-05	0.000945	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PRKAR1A—thyroid cancer	8.99e-05	0.00093	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—RXRA—thyroid cancer	8.84e-05	0.000914	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—HRAS—thyroid cancer	8.83e-05	0.000913	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—thyroid cancer	8.64e-05	0.000894	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MEN1—thyroid cancer	8.59e-05	0.000888	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—HPGD—thyroid cancer	8.33e-05	0.000862	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—TPR—thyroid cancer	8.12e-05	0.00084	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TCF7L1—thyroid cancer	7.81e-05	0.000808	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NDUFA13—thyroid cancer	7.79e-05	0.000806	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PPARG—thyroid cancer	7.79e-05	0.000806	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTCH1—thyroid cancer	7.77e-05	0.000803	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—RXRA—thyroid cancer	7.69e-05	0.000795	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MEN1—thyroid cancer	7.64e-05	0.00079	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CHST14—thyroid cancer	7.33e-05	0.000758	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	7.3e-05	0.000755	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	7.26e-05	0.000751	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	7.24e-05	0.000749	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	7.24e-05	0.000749	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—TPR—thyroid cancer	7.16e-05	0.000741	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.13e-05	0.000737	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SST—thyroid cancer	7.1e-05	0.000735	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PRKAR1A—thyroid cancer	7.05e-05	0.000729	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TP53—thyroid cancer	7.03e-05	0.000728	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	7.01e-05	0.000725	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CALCA—thyroid cancer	6.84e-05	0.000707	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.76e-05	0.000699	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	6.7e-05	0.000693	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—PPARG—thyroid cancer	6.7e-05	0.000693	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.39e-05	0.000661	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDK1—thyroid cancer	6.19e-05	0.00064	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTGS2—thyroid cancer	6.13e-05	0.000634	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HPGD—thyroid cancer	5.91e-05	0.000611	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TPR—thyroid cancer	5.71e-05	0.000591	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	5.7e-05	0.000589	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MINPP1—thyroid cancer	5.65e-05	0.000584	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PRKAR1A—thyroid cancer	5.62e-05	0.000582	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—PPARG—thyroid cancer	5.58e-05	0.000577	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.42e-05	0.000561	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	5.38e-05	0.000557	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MEN1—thyroid cancer	5.37e-05	0.000556	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—SLC5A5—thyroid cancer	5.36e-05	0.000555	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTEN—thyroid cancer	5.34e-05	0.000553	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	5.15e-05	0.000533	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—RXRA—thyroid cancer	5.11e-05	0.000528	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.02e-05	0.00052	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	4.97e-05	0.000514	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NRG1—thyroid cancer	4.97e-05	0.000514	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NDUFA13—thyroid cancer	4.8e-05	0.000497	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—TPR—thyroid cancer	4.79e-05	0.000495	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	4.78e-05	0.000495	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PRKAR1A—thyroid cancer	4.71e-05	0.000487	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.56e-05	0.000471	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CHST14—thyroid cancer	4.51e-05	0.000467	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—RXRA—thyroid cancer	4.5e-05	0.000466	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TERT—thyroid cancer	4.46e-05	0.000461	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.38e-05	0.000453	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CALCA—thyroid cancer	4.28e-05	0.000442	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.27e-05	0.000441	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HIF1A—thyroid cancer	4.27e-05	0.000441	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	4.04e-05	0.000418	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDK1—thyroid cancer	3.87e-05	0.000401	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	3.82e-05	0.000395	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HPGD—thyroid cancer	3.64e-05	0.000376	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—AKT1—thyroid cancer	3.62e-05	0.000375	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SLC5A5—thyroid cancer	3.58e-05	0.000371	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—BRAF—thyroid cancer	3.53e-05	0.000365	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—TPR—thyroid cancer	3.39e-05	0.000351	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	3.39e-05	0.000351	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PRKAR1A—thyroid cancer	3.34e-05	0.000345	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PPARG—thyroid cancer	3.22e-05	0.000334	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NRG1—thyroid cancer	3.11e-05	0.000321	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—AKT1—thyroid cancer	3.08e-05	0.000319	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—RXRA—thyroid cancer	3.01e-05	0.000311	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.93e-05	0.000303	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.86e-05	0.000296	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PPARG—thyroid cancer	2.84e-05	0.000294	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TERT—thyroid cancer	2.79e-05	0.000289	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HIF1A—thyroid cancer	2.67e-05	0.000276	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCND1—thyroid cancer	2.58e-05	0.000267	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SLC5A5—thyroid cancer	2.54e-05	0.000263	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTEN—thyroid cancer	2.49e-05	0.000257	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTGS2—thyroid cancer	2.24e-05	0.000231	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NRAS—thyroid cancer	2.22e-05	0.00023	CbGpPWpGaD
Betamethasone—PTGS2—Disease—BRAF—thyroid cancer	2.21e-05	0.000229	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—AKT1—thyroid cancer	2.21e-05	0.000228	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—RXRA—thyroid cancer	2.13e-05	0.000221	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TPR—thyroid cancer	2.09e-05	0.000216	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	2.06e-05	0.000213	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTEN—thyroid cancer	1.95e-05	0.000202	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KRAS—thyroid cancer	1.91e-05	0.000198	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PPARG—thyroid cancer	1.9e-05	0.000197	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—thyroid cancer	1.7e-05	0.000176	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HRAS—thyroid cancer	1.62e-05	0.000168	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.56e-05	0.000162	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PTEN—thyroid cancer	1.56e-05	0.000161	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKT1—thyroid cancer	1.43e-05	0.000148	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NRAS—thyroid cancer	1.39e-05	0.000144	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPARG—thyroid cancer	1.35e-05	0.000139	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—RXRA—thyroid cancer	1.31e-05	0.000136	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PTEN—thyroid cancer	1.3e-05	0.000135	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—AKT1—thyroid cancer	1.28e-05	0.000132	CbGpPWpGaD
Betamethasone—PTGS2—Disease—KRAS—thyroid cancer	1.2e-05	0.000124	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKT1—thyroid cancer	1.12e-05	0.000116	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTGS2—thyroid cancer	1.06e-05	0.00011	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HRAS—thyroid cancer	1.02e-05	0.000105	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTEN—thyroid cancer	9.24e-06	9.56e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKT1—thyroid cancer	8.97e-06	9.28e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPARG—thyroid cancer	8.3e-06	8.59e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKT1—thyroid cancer	7.51e-06	7.77e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTGS2—thyroid cancer	6.53e-06	6.75e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTEN—thyroid cancer	5.69e-06	5.89e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKT1—thyroid cancer	5.33e-06	5.51e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKT1—thyroid cancer	3.28e-06	3.39e-05	CbGpPWpGaD
